Phosphocholine

Phosphocholine

SCHEMBL1557025

CCCCCCCCCCCCCCCCCC(=O)O[C@@H](CO)[C@H](O)C(=O)CCCCCCCCCCCCC.C[N+](C)(C)CCOP(=O)([O-])O

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.53
NR5A2 O00482 1/20 0.53
NR5A1 Q13285 1/20 0.53
FABP3 P05413 1/20 0.51
RECQL P46063 1/20 0.49
MAPT P10636 1/20 0.48
LPAR6 P43657 1/20 0.45
LPAR1 Q92633 1/20 0.45
LPAR4 Q99677 1/20 0.45
LPAR5 Q9H1C0 1/20 0.45
LPAR2 Q9HBW0 1/20 0.45
LPAR3 Q9UBY5 1/20 0.45
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.43
ESR1 P03372 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
CDC25A P30304 1/20 0.43
AGTR1 P30556 1/20 0.43
AKT1 P31749 1/20 0.43
ADRA1A P35348 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphocholine SCHEMBL5087547 0.92 ALDH1A1 (0.56) SMN1; SMN2NR5A2NR5A1FABP3RECQL
Phosphocholine SCHEMBL6534600 0.91 ALDH1A1 (0.58) SMN1; SMN2NR5A2NR5A1FABP3RECQL
Phosphocholine SCHEMBL3713381 0.86 S1PR1 (0.53) SMN1; SMN2NR5A2NR5A1FABP3LPAR6
Phosphocholine SCHEMBL3960127 0.85 SMN1; SMN2 (0.53) SMN1; SMN2NR5A2NR5A1FABP3RECQL
SCHEMBL825278 0.84 SMN1; SMN2 (0.67) SMN1; SMN2NR5A2NR5A1RECQLMAPT
SCHEMBL17065552 0.84 SMN1; SMN2 (0.67) SMN1; SMN2NR5A2NR5A1RECQLMAPT
SCHEMBL30986129 0.84 SMN1; SMN2 (0.67) SMN1; SMN2NR5A2NR5A1RECQLMAPT
SCHEMBL538239 0.84 FABP3 (0.52) SMN1; SMN2FABP3LPAR1ALDH1A1
SCHEMBL17165009 0.84 LMNA (0.54) SMN1; SMN2NR5A2NR5A1RECQLMAPT
SCHEMBL673766 0.82 SMN1; SMN2 (0.59) SMN1; SMN2NR5A2NR5A1FABP3RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2304026-A2 NANOPARTICLE COMPOSITIONS FOR NUCLEIC ACIDS DELIVERY SYSTEM Enzon Pharmaceuticals, Inc. (US) 2011-04-06 EP disclosed
WO-2010014895-A2 NANOPARTICLE COMPOSITIONS FOR NUCLEIC ACIDS DELIVERY SYSTEM ENZON PHARMACEUTICALS, INC. (US) 2010-02-04 WO disclosed